Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

NCT00003362 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: QS21
BIOLOGICAL: gp100 antigen
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: sargramostim
BIOLOGICAL: tyrosinase peptide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]